Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Catechin is a flavan-3-ol and a type of polyphenolic compound belonging to the flavonoid class. It is found abundantly in woody plants and is a major component of green tea and other dietary sources. Catechins exist as several stereoisomers, including (+)-catechin and (-)-epicatechin. They are known for their potent antioxidant properties, acting both directly by scavenging reactive oxygen species (ROS) and chelating metal ions, as well as indirectly by inducing antioxidant enzymes and inhibiting pro-oxidant enzymes[6][4]. Catechins modulate key cellular pathways such as NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells), Nrf2 (nuclear factor erythroid 2–related factor 2), TLR4/NF-κB, COMT (catechol-O-methyltransferase), MAPKs (mitogen-activated protein kinases), and receptor tyrosine kinases[3][6]. These actions contribute to their anti-inflammatory, anti-diabetic, anti-cancer, neuroprotective, bactericidal, memory-enhancing, anti-arthritic, hepato-protective effects[3]. Catechins are also known to influence drug pharmacokinetics by affecting drug transporters such as OATP (organic anion transporting polypeptides) which can decrease intestinal absorption of certain medications[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Catechin.